EXCLUSIVE: Kaleidoscope Film Distribution has picked up world sales rights (excluding UK & Ireland) from Gerard Johnson’s (Tony) Odyssey, which debuted at this year’s SXSW Film Festival.

Doctor Odyssey has taken huge swings all season but did the ABC series just go too far by potentially killing off Joshua Jackson? During the penultimate episode, which aired on Thursday ...

While Clair Obscur: Expedition 33 has a beautiful map, you may find that the item or location you're looking for doesn't appear on it. This can be especially true for collectibles, like the Lost ...

If this really is the end for Doctor Odyssey, Ryan Murphy is going down like the captain of the Titanic and having the orchestra play him out. **Spoilers ahead for Doctor Odyssey Episode 17** This ...

The Samsung Odyssey Ark 2nd Gen is $900 off right now, bringing the cost down to $1,799.99. Buy the Samsung Odyssey Ark 2nd Gen for $1,799.99 ($900 off) This offer is available from Amazon.

And every location is a hike.” The stunt performer claimed that Nolan’s The Odyssey is going to be an 'epic of all epics'. It is going to be a movie no one’s have ever made.

Odyssey is stepping up its game in the zero-torque space. With zero torque putting being the talk of professional and amateur golf, the company is releasing the high-MOI Square 2 Square Max 1 and ...

With performances by Moby, Empire of the Sun and others, the concerts incorporate immersive 8K projections, spatial ...

Narratives from the “Odyssey” and “Star Wars” to “Eat Pray Love” and “Wild” employ a similar framework, in which lead characters set out on their own in order to pursue a life ...

(The Center Square) – A new lawsuit challenging Wisconsin’s congressional maps has been filed with the Wisconsin Supreme Court with Elias Law Group representing nine Wisconsin voters.

The Odyssey stunt trainer James Newman offered an insight into what Tom Holland and Matt Damon actions scenes looks like. The upcoming film directed by Oscar winner, Christopher Nolan follows the ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...